DMCC Speciality Chemicals Gains 2.97%: Mixed Technical Signals and Valuation Shifts Shape the Week

22 June 2026: Technical Momentum Shifts Amid Mixed Signals

On 22 June, DMCC Speciality Chemicals Ltd closed at Rs.253.80, up 0.63% from the previous close, outperforming the Sensex which rose 0.46% that day. The stock exhibited a subtle shift from a sideways trend to a mildly bullish stance, supported by daily moving averages and weekly Bollinger Bands. However, mixed signals from MACD, RSI, and Dow Theory across weekly and monthly timeframes suggested a nuanced outlook. The stock traded within a narrow range of Rs.247.75 to Rs.252.75, remaining well below its 52-week high of Rs.349.85 but comfortably above its 52-week low of Rs.195.00.

Despite the short-term technical improvement, longer-term indicators such as monthly MACD and RSI remained bearish, signalling caution. The MarketsMOJO score at this point was 58.0, with a Hold rating reflecting improved but cautious sentiment. The stock’s micro-cap status added to volatility concerns, while the sector’s cyclical nature and raw material price sensitivity continued to influence momentum.

22 June 2026: Valuation Upgrade Signals Renewed Price Attractiveness

Also on 22 June, DMCC’s valuation parameters improved, shifting from very attractive to attractive. The price-to-earnings (P/E) ratio stood at 23.01, favourable compared to peers such as Stallion India (P/E 49.87) and Sanstar Chemicals (P/E 60.04). The price-to-book value (P/BV) ratio was 2.53, indicating a moderate premium over net asset value. Enterprise value multiples, including EV/EBITDA at 11.23 and EV/EBIT at 14.96, suggested conservative earnings valuation relative to competitors.

The PEG ratio of 0.85 implied undervaluation relative to earnings growth, supported by a dividend yield near 1%. Profitability metrics such as ROCE at 14.39% and ROE at 11.01% underpinned the valuation upgrade. Despite mixed recent returns, the stock’s 10-year return of 276.14% significantly outpaced the Sensex’s 188.45%, highlighting long-term growth potential amid short-term volatility.

24 June 2026: Downgrade to Sell Amid Mixed Fundamentals and Technical Weakness

On 24 June, DMCC Speciality Chemicals Ltd’s rating was downgraded from Hold to Sell by MarketsMOJO, reflecting deteriorating technical indicators and modest financial trends. The stock closed at Rs.251.20, down 0.12% from the previous day, while the Sensex gained 0.53%. Technical momentum softened from mildly bullish to sideways, with weekly MACD mildly bearish and monthly MACD outright bearish. RSI readings were neutral weekly but bearish monthly, and Bollinger Bands on weekly and monthly charts turned bearish, indicating increased volatility and downward pressure.

Financially, the company showed flat quarterly results with operating profit growth averaging 10.65% annually over five years. Interest expenses surged 45.89% to Rs.3.37 crores, reducing the operating profit to interest coverage ratio to 5.25 times. The debt-equity ratio rose to 0.35 times, the highest recorded, signalling increased leverage risk. Despite an attractive valuation with a P/E of 22.77 and EV/EBITDA of 11.13, the stock’s underperformance against benchmarks and minimal institutional holding (0.02%) tempered optimism.

25 June 2026: Technical Momentum Shifts to Sideways Amid Mixed Market Signals

On 25 June, the stock closed at Rs.251.20, marginally down 0.12% from the previous close, with intraday prices ranging between Rs.246.25 and Rs.257.50. Technical momentum shifted further towards a sideways trend amid conflicting signals. Daily moving averages remained mildly bullish, but weekly and monthly indicators such as MACD and RSI were bearish or neutral. Bollinger Bands on weekly and monthly charts were bearish, suggesting potential downward momentum.

Additional indicators like the weekly Know Sure Thing (KST) oscillator were bullish, while monthly KST remained bearish. Dow Theory showed no clear weekly trend but a mildly bullish monthly trend. On-balance volume was bullish monthly but lacked a weekly trend, indicating possible longer-term accumulation despite short-term weakness. Relative to the Sensex, DMCC underperformed over the week and month but showed resilience year-to-date.

Daily Price Performance vs Sensex

Key Takeaways

Positive Signals: The stock outperformed the Sensex over the week with a 2.97% gain versus a 0.11% decline in the benchmark, supported by a valuation upgrade to attractive and a brief technical momentum shift to mildly bullish. Profitability metrics such as ROCE and ROE remain solid, and the PEG ratio below 1 suggests undervaluation relative to growth. The 10-year return of over 276% highlights strong long-term capital appreciation potential.

Cautionary Signals: The downgrade to Sell by MarketsMOJO on 24 June reflects weakening technical momentum and modest financial trends, including rising interest expenses and increased leverage. Monthly technical indicators remain bearish, and the sideways trend suggests limited near-term upside. The stock’s micro-cap status entails higher volatility and lower liquidity, compounded by minimal institutional ownership. Recent underperformance over one to five years versus the Sensex underscores ongoing challenges.

Conclusion

DMCC Speciality Chemicals Ltd’s week was characterised by a complex interplay of technical shifts, valuation reassessments, and analyst rating changes. While the stock demonstrated resilience by gaining 2.97% and outperforming the Sensex, mixed technical signals and deteriorating fundamentals prompted a cautious downgrade. The valuation remains attractive relative to peers, supported by solid profitability metrics, but rising leverage and flat financial trends temper enthusiasm.

Investors should monitor the evolving technical indicators closely, particularly the monthly MACD and RSI, to gauge whether the stock can sustain upward momentum or faces further pressure. The micro-cap nature of DMCC adds risk and volatility, making it essential to weigh both the positive valuation signals and the cautionary fundamentals before considering exposure.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today